T. GÜNGÖR Et Al. , "PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY-2: Novel amide/Ntr combinations targeting PC3 cancer cells," EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.171, pp.383-400, 2019
GÜNGÖR, T. Et Al. 2019. PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY-2: Novel amide/Ntr combinations targeting PC3 cancer cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.171 , 383-400.
GÜNGÖR, T., CÖMERT ÖNDER, F., Tokay, E., Gulhan, U. G., Hacioglu, N., Tok, T. T., ... Celik, A.(2019). PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY-2: Novel amide/Ntr combinations targeting PC3 cancer cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.171, 383-400.
GÜNGÖR, TUĞBA Et Al. "PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY-2: Novel amide/Ntr combinations targeting PC3 cancer cells," EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.171, 383-400, 2019
GÜNGÖR, TUĞBA Et Al. "PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY-2: Novel amide/Ntr combinations targeting PC3 cancer cells." EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.171, pp.383-400, 2019
GÜNGÖR, T. Et Al. (2019) . "PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY-2: Novel amide/Ntr combinations targeting PC3 cancer cells." EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.171, pp.383-400.
@article{article, author={TUĞBA GÜNGÖR Et Al. }, title={PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY-2: Novel amide/Ntr combinations targeting PC3 cancer cells}, journal={EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY}, year=2019, pages={383-400} }